120 related articles for article (PubMed ID: 38085131)
1. Network connectivity between psychological resilience and depression in prostate cancer patients.
Sharpley CF; Arnold WM; Christie DRH; Bitsika V
Psychooncology; 2024 Jan; 33(1):e6266. PubMed ID: 38085131
[TBL] [Abstract][Full Text] [Related]
2. Network analysis of depression in prostate cancer patients: Implications for assessment and treatment.
Sharpley CF; Christie DRH; Arnold WM; Bitsika V
Psychooncology; 2023 Mar; 32(3):368-374. PubMed ID: 36514194
[TBL] [Abstract][Full Text] [Related]
3. Does resilience 'buffer' against depression in prostate cancer patients? A multi-site replication study.
Sharpley CF; Bitsika V; Wootten AC; Christie DR
Eur J Cancer Care (Engl); 2014 Jul; 23(4):545-52. PubMed ID: 24506500
[TBL] [Abstract][Full Text] [Related]
4. Effects of social support, hope and resilience on depressive symptoms within 18 months after diagnosis of prostate cancer.
Zhao X; Sun M; Yang Y
Health Qual Life Outcomes; 2021 Jan; 19(1):15. PubMed ID: 33413485
[TBL] [Abstract][Full Text] [Related]
5. Which Aspects of Psychological Resilience Moderate the Association between Deterioration in Sleep and Depression in Patients with Prostate Cancer?
Sharpley CF; Christie DRH; Bitsika V
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886356
[TBL] [Abstract][Full Text] [Related]
6. Psychometric validation of the French version of the Connor-Davidson Resilience Scale.
Guihard G; Deumier L; Alliot-Licht B; Bouton-Kelly L; Michaut C; Quilliot F
Encephale; 2018 Feb; 44(1):40-45. PubMed ID: 28870690
[TBL] [Abstract][Full Text] [Related]
7. Limitations in the inverse association between psychological resilience and depression in prostate cancer patients experiencing chronic physiological stress.
Sharpley CF; Christie DRH; Bitsika V; Agnew LL; Andronicos NM; McMillan ME; Richards TM
Psychooncology; 2018 Jan; 27(1):223-228. PubMed ID: 28692205
[TBL] [Abstract][Full Text] [Related]
8. The association between aspects of psychological resilience and subtypes of depression: implications for focussed clinical treatment models.
Sharpley CF; Bitsika V; Jesulola E; Fitzpatrick K; Agnew LL
Int J Psychiatry Clin Pract; 2016 Sep; 20(3):151-6. PubMed ID: 27332989
[TBL] [Abstract][Full Text] [Related]
9. Do prostate cancer patients suffer more from depressed mood or anhedonia?
Sharpley CF; Bitsika V; Christie DH
Psychooncology; 2013 Aug; 22(8):1718-23. PubMed ID: 23019092
[TBL] [Abstract][Full Text] [Related]
10. Psychological resilience aspects that mediate the depressive effects of urinary incontinence in prostate cancer survivors 10 years after treatment with radiation and hormone ablation.
Sharpley CF; Bitsika V; Christie DRH; Bradford R; Steigler A; Denham JW
J Psychosoc Oncol; 2017; 35(4):438-450. PubMed ID: 28318448
[TBL] [Abstract][Full Text] [Related]
11. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
Cerbo AD
Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
[TBL] [Abstract][Full Text] [Related]
12. 'Steeling' effects in the association between psychological resilience and cancer treatment in prostate cancer patients.
Sharpley CF; Christie DRH; Bitsika V
Psychooncology; 2021 Jan; 30(1):67-73. PubMed ID: 32877009
[TBL] [Abstract][Full Text] [Related]
13. Identifying a stable and generalizable factor structure of major depressive disorder across three large longitudinal cohorts.
Tseng VWS; Tharp JA; Reiter JE; Ferrer W; Hong DS; Doraiswamy PM; Nickels S;
Psychiatry Res; 2024 Mar; 333():115702. PubMed ID: 38219346
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and adjustment in men with prostate cancer: Interplay of stress, threat and resilience.
Groarke A; Curtis R; Skelton J; Groarke JM
PLoS One; 2020; 15(9):e0239469. PubMed ID: 32941547
[TBL] [Abstract][Full Text] [Related]
15. Measuring depression in prostate cancer patients: does the scale used make a difference?
Sharpley CF; Bitsika V; Christie DR; Hunter MS
Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26428948
[TBL] [Abstract][Full Text] [Related]
16. Predicting future major depression and persistent depressive symptoms: Development of a prognostic screener and PHQ-4 cutoffs in breast cancer patients.
Weihs KL; Wiley JF; Crespi CM; Krull JL; Stanton AL
Psychooncology; 2018 Feb; 27(2):420-426. PubMed ID: 28600855
[TBL] [Abstract][Full Text] [Related]
17. Psychological resilience and related influencing factors in patients diagnosed with major depressive disorder in remission: A cross-sectional study.
Wang Q; Gong L; Huang H; Wang Y; Xu T; Dong X
J Psychiatr Ment Health Nurs; 2023 Jun; 30(3):492-500. PubMed ID: 36403213
[TBL] [Abstract][Full Text] [Related]
18. Comparing a genetic and a psychological factor as correlates of anxiety, depression, and chronic stress in men with prostate cancer.
Sharpley CF; Christie DRH; Bitsika V; Andronicos NM; Agnew LL; Richards TM; McMillan ME
Support Care Cancer; 2018 Sep; 26(9):3195-3200. PubMed ID: 29603029
[TBL] [Abstract][Full Text] [Related]
19. African-centered coping, resilience, and psychological distress in Black prostate cancer patients.
Martin CM; Schofield E; Napolitano S; Avildsen IK; Emanu JC; Tutino R; Roth AJ; Nelson CJ
Psychooncology; 2022 Apr; 31(4):622-630. PubMed ID: 34751457
[TBL] [Abstract][Full Text] [Related]
20. Feasibility Study of Stress Management and Resiliency Training (SMART) in Patients With Major Depressive Disorder.
Seshadri A; Clark MM; Kung S; Fuller-Tyszkiewicz M; Sood A; Dammen KC; Rico JA; Tye SJ; McGillivray J; Frye MA
Prim Care Companion CNS Disord; 2020 Apr; 22(3):. PubMed ID: 32369689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
